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PREFACE
WHY THIS ADDENDUM WAS DEVELOPED
 
The goal of this addendum is to help management and staff 
minimize the risk of TB transmission at facilities in resource-
limited settings in which:
 
•	 HIV-infected persons receive diagnosis, care, treatment, 
and/or support, such as voluntary counseling and testing 
centers, clinics for HIV care including primary health care 
clinics, antiretroviral therapy (ART) clinics, and support 
clubs for people living with HIV/AIDS; and
•	 There is a high prevalence of HIV infection, both known 
and undiagnosed, in settings such as prisons, jails, other 
detention centers, and drug rehabilitation centers.
In this era of increasing access to HIV counseling and testing, 
care, and treatment for people living with HIV, more people 
living with HIV-associated immunosuppression are attending 
health care and community facilities than ever before.  
Persons, including health care workers, with HIV-associated 
immunosuppression are particularly vulnerable to developing 
TB disease if they become infected with Mycobacterium  
tuberculosis (M. tuberculosis, the germ that can cause TB) as a 
result of exposure in these settings.  
The Guidelines for the Prevention of Tuberculosis in Health 
Care Facilities in Resource-Limited Settings1 published by the 
World Health Organization in 1999 addresses issues related 
to inpatient facilities.  This document supplements rather than 
replicates that guidance and addresses inpatient facilities only in 
Annex C.   It aims to give the reader a greater understanding of 
the following issues in the context of HIV care settings:
•	 TB transmission in facilities providing services to people 
living with HIV infection and disease;
•	 Infection control procedures to reduce the risk of M. 
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tuberculosis transmission in HIV/AIDS care facilities;
•	 Protection of health care workers and staff through 
HIV voluntary counseling and testing (VCT), increasing 
awareness of TB in staff and preventive action;
•	 Importance of TB infection control in drug rehabilitation 
centers; correctional institutions including prisons, jails, 
other detention centers; and other facilities where large 
numbers of HIV infected individuals gather;
•	 Issues of multi-drug resistant TB (MDRTB).
WHO SHOULD USE THIS ADDENDUM
This document is for policy makers, health care workers, 
administrators, and stake holders in the public, private, and 
nongovernmental health sector involved in providing care and 
treatment to persons with HIV/AIDS.  It can also be helpful for 
persons or institutions responsible for the health and well-being 
of large numbers of persons living with HIV/AIDS (PLWHA).   
Settings include VCT centers, community-based outreach 
centers, ARV and other HIV care clinics, hospices, general 
health care facilities, drug rehabilitation centers, and correctional 
institutions including prisons and jails.  
Note oN the use of “tB”, M. tuberculosis aNd “tB 
suspect” 
The words “tuberculosis (TB)” and “M. tuberculosis,” the 
bacterium that causes TB, are used in different ways.  This 
document uses “TB” to describe clinical events, such as TB 
infection, TB transmission, and TB disease; M. tuberculosis is 
used when describing potentially infectious germs that a person 
with TB disease of the lungs or larynx expels when coughing.   
“TB suspect” refers to a person who presents with symptoms 
or signs suggestive of TB disease, in particular a cough of long 
duration.  
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INTRODUCTION
WHY IS TB A PROBLEM IN HIV CARE SETTINGS?
Persons with undiagnosed, untreated and potentially contagious 
TB are often seen in HIV care settings.  TB is the most common 
opportunistic infection and a leading cause of death in persons 
living with HIV/AIDS (PLWHA).
In high TB burden settings, surveys have shown that up to 10% 
of persons with HIV infection may have previously undiagnosed 
TB at the time of HIV voluntary counseling and testing (VCT), 
including at centers providing prevention-of-mother- to-child HIV 
transmission (PMTCT) services. 2,3,4  Up to half of these may be 
infectious TB cases. 
Between 30% and 40% of PLWHA living in high burden TB 
settings will develop TB in their lifetime, in the absence of 
isoniazid preventive therapy or antiretroviral therapy.5 The risk of 
developing TB disease doubles in the first year after becoming 
HIV-infected and gets progressively higher over time. 6 Persons 
without TB disease at the time of HIV diagnosis may still 
develop TB in later years, and will then be at risk of spreading 
M. tuberculosis in the community as well as to fellow patients, 
healthcare workers, and staff at their HIV care clinics and in 
community programs.  
Persons with HIV-associated immunosuppression may become 
infected or re-infected with TB if they are exposed to someone 
with infectious TB disease.  They can progress rapidly from 
TB infection to disease – over a period of months rather than a 
period of years as is common for persons with a normal immune 
system.    
Health care workers and other staff are also at particularly 
high risk of infection with TB because of frequent exposure 
to patients with infectious TB disease.  Health care workers 
and staff may themselves be immunosuppressed due to HIV 
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infection and be at higher risk of developing TB disease once 
infected.  
Multiple TB outbreaks affecting HIV-infected patients and 
health care workers due to health care facility exposures 
were documented in industrialized countries in the 1990s. 
7 These coincided with the early period of the HIV epidemic, 
before TB infection control procedures in health care facilities 
were strengthened.  This document provides information on 
measures that can be taken, even in resource-limited settings, 
to prevent unnecessary morbidity and mortality due to TB 
transmission in health care settings.
Work practice, administrative control measures and 
environmental control measures are the focus of this addendum. 
Other issues addressed are HIV and TB in health care workers 
and staff, and protecting their health; MDRTB; and specialized 
facilities such as drug rehabilitation centers.
HOW IS TB SPREAD?
TB is caused by M tuberculosis.  People who have TB 
disease in their lungs can release tiny particles containing M. 
tuberculosis into the air by coughing.  These particles are called 
droplet nuclei.  They are invisible to the naked eye. Droplet 
nuclei can remain airborne in room air for many hours, until they 
are removed by natural or mechanical ventilation.
To spread, there must be a source, a person with TB disease 
who produces M. tuberculosis, and an exposed person to 
inhale droplet nuclei containing the bacteria.  Although TB is not 
usually spread by brief contact, anyone who shares air with a 
person with TB disease of the lungs in an infectious stage is at 
risk.  A person who inhales one or more of the droplet nuclei can 
become infected with M. tuberculosis.
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HOW IS TB DISEASE IN THE LUNGS DIAGNOSED
The most common part of the body to have TB disease is the 
lungs.  In resource-limited settings TB disease in the lungs is 
diagnosed by examining samples of sputum with a microscope.  
The sputum is smeared onto a small glass plate, stained with 
chemicals, and viewed under the microscope.  If M. tuberculosis 
bacilli are present, they can often (but not always) be seen.  
These diagnostic tests are referred to as “sputum smears”.   
Sometimes chest radiography is done to assist with making the 
diagnosis.
VACCINATION WITH BCG
The Bacille Calmette-Guérin (BCG) vaccine is a live vaccine 
derived from a strain of Mycobacterium bovis (similar to M. 
tuberculosis) first administered to humans in 1921.  Since 
that time, many different strains have been derived and are 
used today throughout the world to prevent TB disease.  BCG 
vaccination reduces the risk for progression from latent TB 
infection to TB disease, especially disseminated or central 
nervous system disease in children.  BCG vaccination may 
cause a positive reaction to a tuberculin skin test.  
THE DIFFERENCE BETWEEN TB INFECTION AND TB 
DISEASE
TB Infection
•	 TB infection is the state of having a small number of M. 
tuberculosis bacteria in the body which are unable to 
grow due to control by the immune system.  The bacteria 
are inactive, but remain alive in the body and can 
become active later.  This condition is also referred to as 
latent TB infection (LTBI). 
•	 TB infection does not cause a person to feel sick, and 
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there are no symptoms, nor are there signs detected 
upon medical evaluation.
•	 A tuberculin skin test is the main method used to 
diagnose TB infection.  A positive result usually means 
that TB infection is present, but persons with HIV-
associated immunosuppression can have a false 
negative TB skin test even with TB infection.  Also, 
persons who have received BCG vaccination may have a 
false positive skin test.
•	 Only one out of 10 people with TB infection and a normal 
immune system will develop TB disease in their lifetime. 
For persons with HIV infection and TB infection, one out 
of 10 each year will develop TB disease.
•	 Treatment for TB infection with the anti-TB drug isoniazid 
can reduce the risk that TB disease will develop, though 
the protective benefit only lasts about two years in 
persons with HIV infection.
TB Disease
•	 Most TB disease occurs in the lungs.  In persons with 
HIV infection, up to half of TB cases have disease in 
other parts of the body.
•	 A person with TB disease of the lungs usually has a 
cough and sometimes coughs up blood.
•	 General symptoms of TB disease include fever, sweating 
at night, loss of appetite, weight loss, and fatigue.
•	 With standard treatment TB disease can be cured, even 
in persons with HIV infection. 
•	 Untreated TB is often fatal, especially in persons infected 
with HIV.
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TB Infection versus TB Disease 
TB Infection TB Disease (in the 
lungs) 
M. tuberculosis in the body
Tuberculin skin test reaction usually positive
No symptoms Symptoms such as 
cough, fever, weight 
loss
Chest x-ray usually 
normal
Chest x-ray usually 
abnormal
Sputum smears and 
cultures negative
Sputum smears 
and cultures usually 
positive*
Not infectious Often infectious 
before treatment
Not a case of TB A case of TB
* Sputum smears more often negative in HIV-infected TB cases
WHEN TB IS INFECTIOUS
TB can be infectious when it occurs in the lungs or larynx.  In 
general, a person with TB disease of the lungs or larynx should 
be considered infectious until the person:
•	 Has completed at least two weeks of standard anti-
TB therapy, preferably with direct observation by a TB 
program-appointed treatment supervisor; and
•	 Has had three consecutive negative sputum smears on 
three different days, with at least one morning specimen;* 
and
•	 Has improvement in symptoms.
A TB suspect should be considered infectious until a diagnostic 
investigation is completed.
* Note:  Frequent evaluation of AFB sputum smear status may not be done routinely 
in resource-limited settings.
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HOW TO REDUCE THE RISK OF SPREADING M. 
TUBERCULOSIS  IN HIV CARE SETTINGS
It is very likely that persons with infectious TB will be found in 
HIV care settings. There is also a strong likelihood that these 
persons will spread M. tuberculosis  to other persons, including 
immunocompromised patients or staff. However, there are 
interventions which can significantly reduce this risk. 8 There are 
two main ways in which even settings with limited resources can 
reduce the chances that TB will spread:
1. work practice and administrative control measures
2. environmental control measures 
In general, work practice and administrative control measures 
have the greatest impact on preventing TB transmission within 
settings, and they are the first priority in any setting regardless 
of available resources.  These measures prevent droplet nuclei 
containing M. tuberculosis from being generated in the facility, 
and thus reduce exposure of patients and staff to TB.  Ideally, 
if generation of droplet nuclei is eliminated then exposure is 
eliminated; no further controls are needed.  However, since it 
is not possible to eliminate all exposure, environmental control 
measures must be added to reduce the concentration of 
droplet nuclei in the air.  Although many environmental control 
measures require resources not available in resource-limited 
settings, some can be implemented, and staff can be trained in 
their purpose, capabilities, proper operation, and maintenance.
WORK PRACTICE AND ADMINISTRATIVE CONTROLS
Work practice and administrative control measures have the 
greatest impact on preventing TB transmission within facilities 
caring for PLWHA.  They serve as the first line of defense 
for preventing the spread of TB in HIV care settings.  Their 
goals are [1] to prevent TB exposure to staff and patients, 
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and [2] to reduce the spread of infection by ensuring rapid 
and recommended diagnostic investigation and treatment for 
patients and staff suspected or known to have TB. This can best 
be  accomplished through the prompt recognition, separation, 
provision of services, and referral of persons with potentially 
infectious TB disease.  
There are five components to good work practice and 
administrative controls:
•	 Infection control plan;
•	 Administrative support for procedures in the plan, 
including quality assurance;
•	 Training of staff;
•	 Education of patients and increasing community 
awareness; and
•	 Coordination and communication with the TB program.
INFECTION CONTROL PLAN
Each facility should have a written TB infection control plan 
that outlines a protocol for the prompt recognition, separation, 
provision of services, investigation for TB and referral of patients 
with suspected or confirmed TB disease.
Early recognition of patients with suspected or confirmed TB 
disease is the first step in the protocol.  A staff member should 
be assigned to screen patients for prolonged duration of cough 
immediately after they arrive at the facility.  Patients with cough 
should be allowed to enter, register, and get a card without 
standing in line with other patients.  
Patients who are identified as TB suspects on the screening 
must be given advice on respiratory hygiene/cough etiquette, 
and provided with a face mask (e.g., surgical mask) or tissues to 
cover their mouths and noses.  They should then be separated 
from other patients and requested to wait in a separate well-
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ventilated waiting area. 
Placing symptomatic patients at the front of the line, to quickly 
provide care and reduce the amount of time that others are 
exposed to them, is recommended.  
Some patients who are found to have symptoms suggestive 
of TB may have attended the clinic for another reason. If 
possible, these patients should receive the services they were 
originally accessing (e.g. VCT, medication refills) before being 
investigated for TB or referred to the TB diagnostic center.  In an 
integrated service delivery setting, if possible, the patient should 
receive the services they are accessing before TB investigation.
TB suspects should promptly be investigated for TB following 
national protocols. If TB diagnostic services are not available 
onsite, the facility should have an established link with a 
TB diagnostic center to which symptomatic patients can be 
referred.  Also, each facility should have a linkage with a TB 
treatment center to which those who are diagnosed with TB can 
be referred (see Coordination and Communication between 
TB and HIV/AIDS Care Programs).  Ideally, sputum samples 
should be collected and sent to the nearest laboratory.  Sputum 
collection always should be done in a designated area with a 
lot of air circulation and away from other people, not in small 
rooms such as toilet rooms or other enclosed areas.   If this is 
not possible the patient should be referred to the nearest TB 
diagnostic center. Every attempt should be made to facilitate this 
referral (e.g., through subsidizing transport costs or incentives) 
as further delays in diagnosis will increase the risk of exposing 
others to TB infection.
The plan should designate a staff member to be the infection 
control officer who is responsible for ensuring the infection 
control procedures are implemented.  The plan will include, but 
not be limited to, the following policy areas:
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1.  Screening all patients as soon as possible after arrival at 
the facility to identify persons with symptoms of TB disease 
or persons who are being investigated or treated for TB 
disease.
2.  Instructing the above designated persons identified 
through screening in respiratory hygiene/cough etiquette.  
This includes instructing them to cover their nose and mouth 
when coughing for sneezing, and when possible providing 
face masks or tissues to assist them in covering their 
mouths.  
   
Face masks help prevent the spread of M. tuberculosis from 
the patient to others.  The face mask can capture large wet 
particles near the mouth and nose of the patient, preventing 
the bacteria from being released into the environment.  Face 
masks could be provided to persons who have a positive 
symptom screen to wear until they leave the facility.  Cloth 
masks can be sterilized and reused.  Paper tissues provided 
to these persons, with instructions to cover their mouths and 
noses when coughing or sneezing, are less costly and also 
less likely to identify people as TB suspects with attendant 
risk of stigma.  However, they are less likely to be used 
effectively.   (See A Note on Personal Respiratory Protection)
Tissues and face masks should be disposed in waste 
receptacles.  Clients and especially staff should be 
encouraged to wash their hands after contact with 
respiratory secretions.  M. tuberculosis cannot be spread 
from the hands, but other serious lung infections can.
3.  Placing TB suspects and cases in a separate well-
ventilated waiting area such as a sheltered open-air space is 
ideal in warm climates.
4.  Speeding up management of these persons so that they 
spend as little time as possible at the facility.
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5.  Ensuring rapid diagnostic investigation of TB suspects, 
including referring TB suspects to TB diagnostic services if 
not available on site; and ensuring that persons reporting TB 
treatment are adhering with their treatment.
6.  Using and maintaining environmental control measures 
(see Environmental Control Measures).
7.  Training and educating all staff on TB and the TB infection 
control plan (training should include special risks for TB for 
HIV-infected persons, and need for diagnostic investigation 
for those with signs or symptoms of TB). 
8.  Providing voluntary, confidential HIV counseling and 
testing for staff with adequate access to treatment. 
9. Monitoring the TB infection control plan’s implementation 
and correcting any inappropriate practices or failure to 
adhere to institutional policies. 
(See Annex A.1.  Sample infection control plan) 
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Five Steps for Patient Management




Early recognition of patients with suspected or confirmed 
TB disease is the first step in the protocol.  It can be 
achieved by assigning a staff member to screen patients 
for prolonged duration of cough immediately after they 
arrive at the facility.  Patients with cough of more than two 
weeks duration, or who report being under investigation or 
treatment for TB*, should not be allowed to wait in the line 
with other patients to enter, register, or get a card.  Instead, 
they should be managed as outlined below.  
. Educate
Instructing the above mentioned persons identified through screening 
in cough hygiene.  This includes instructing them to cover their noses 
and mouths when coughing or sneezing, and when possible providing 
face masks or tissues to assist them in covering their mouths.  
. Separate
Patients who are identified as TB suspects or cases by the 
screening questions must be separated from other patients 
and requested to wait in a separate well-ventilated waiting 
area, and provided with a surgical mask or tissues to cover 
their mouths and noses while waiting.  
. Provide HIV services
Triaging symptomatic patients to the front of the line for the 
services they are seeking (e.g. voluntary HIV counseling 
and testing, medication refills), to quickly provide care and 
reduce the amount of time that others are exposed to them 
is recommended.  In an integrated service delivery setting, 
if possible, the patient should receive the HIV services they 
are accessing before the TB investigation.
. Investigate for TB or
Refer
TB diagnostic tests should be done onsite or, if not available 
onsite, the facility should have an established link with a 
TB diagnostic center to which symptomatic patients can be 
referred.  Also, each facility should have a linkage with a TB 
treatment center to which those who are diagnosed with TB 
can be referred.
*Although TB patients on adequate treatment are no 
longer infectious, it may be difficult for the facility to 
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determine if anyone reporting being on treatment for 
TB has indeed received adequate treatment.  The most 
cautious procedure is to manage those who are on 
treatment in the manner described.
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ADMINISTRATIVE SUPPORT
Each facility should appoint one person to serve as the infection 
control officer.  Larger facilities may also have a committee. 
The officer is responsible for overseeing the infection control 
committee and developing a written infection control plan, 
monitoring its implementation, and providing effective training 
for health care workers and other staff.   (See Annex A.2. 
Sample monitoring tools)
TRAINING OF STAFF 
Infection control is effective only if all staff working in a facility 
understands the importance of the infection control policies and 
their role in implementing them.  As part of training, each health 
care worker and staff member, including any lay workers, should 
receive job category-specific instruction.  Training should be 
conducted before initial assignment and continuing education 
should be provided to all employees and volunteers annually.  
Training should include the seven issues below:
•	 Basic concepts of M. tuberculosis transmission and 
pathogenesis (i.e., the difference between infection and 
disease);
•	 Risk of TB transmission to health care workers and staff
•	 symptoms and signs of TB;
•	 Impact of HIV infection on increasing risk of developing 
TB disease and the importance of TB as a major cause of 
disease and death in PLWHA;
•	 Importance of the infection control plan and the 
responsibility that each staff member has to implement 
and maintain infection control practices;
•	 Specific infection control measures and work practices 
that reduce the likelihood of transmitting TB; and
•	 Measures staff can take to protect themselves from TB. 
(See Annex A.3.  Training materials for staff)
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EDUCATION OF PATIENTS AND COMMUNITY AWARENESS
As noted in the introduction, up to one-third or more of HIV-
infected persons living in areas with widespread TB will develop 
TB disease during their lifetime.  Educating communities and 
patients to recognize symptoms of TB and to seek health 
care and further investigations should be routine in settings 
providing care for HIV-infected persons.   In addition, patients 
should understand how to protect themselves, and others, 
from exposure to TB by simple cough hygiene measures.  (See 
Annex A.4. Patient education materials)
COORDINATION AND COMMUNICATION BETWEEN TB AND 
HIV/AIDS CARE PROGRAMS
Coordination and communication between HIV/AIDS and 
TB programs is one aspect of a major initiative of STOP TB 
Department of the World Health Organization to prevent 
TB in persons with HIV.  In most countries, national TB/HIV 
coordinating bodies are being established with a goal of having 
similar committees at every level of health care service.  Each 
facility caring for persons with HIV should determine what 
coordinating mechanisms already exist at their local level.  Each 
facility without an integrated system providing care for both 
TB and HIV should develop an agreement with the local TB 
program which establishes: 
•	 A referral mechanism for patients suspected of having 
TB disease to be investigated in the TB diagnostic center 
and started on treatment, if indicated; and 
•	 A monitoring mechanism which provides feedback to 
the referring facility to evaluate both the linkage with TB 
diagnostic services and the appropriateness of referrals 
as indicated by the proportion of suspects actually 
confirmed as having TB disease.  (See Annex A.2 
Sample monitoring tools)
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PERSONAL RESPIRATORY PROTECTION
Personal respiratory protection (i.e., the selection, training, 
and use of respirators) is not a priority intervention in the HIV 
care settings addressed in this addendum.  Respirators can 
protect health care workers from inhaling M. tuberculosis only 
if standard work practice and environmental controls are in 
place. In addition, they are expensive to purchase and require 
specialized equipment to determine proper fit.  Frequently, they 
are unavailable in resource-limited settings.  Their use should 
be restricted to specific high risk areas in hospitals and referral 
centers, such as rooms where spirometry or bronchoscopy are 
performed or specialized treatment centers for persons with 
MDRTB.  
If a respirator is needed, a U.S.-certified N95 (or greater) 
or EU-certified FFP2 (or greater) respirator should be used.  
Respirators are different from face masks, such as surgical 
masks made of cloth or paper. Use of a face mask does not 
protect health care workers, other staff, patients, or visitors 
against TB.  Therefore, it is NOT recommended that health care 
workers and other staff or visitors in HIV care settings wear 
them.
For more detailed information, please refer to pages 45-48 of 
the Guidelines for the prevention of tuberculosis in health care 
facilities in resource-limited settings. 1
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ENVIRONMENTAL CONTROL MEASURES
Environmental controls are the second line of defense for 
preventing the spread of TB in HIV care settings.  It is important 
to recognize that if work practice or administrative controls are 
inadequate, environmental controls will not eliminate the risk.  
Environmental controls include: 
•	 Ventilation (natural and mechanical), 
•	 Filtration, and 
•	 Ultraviolet germicidal irradiation.  
Many environmental control measures are technologically 
complex and expensive, and therefore only practical for referral 
hospitals.  However, controlled natural ventilation can reduce 
the risk of spreading M. tuberculosis.  
Face mask – has large pores and 
lacks air tight seal around edges 
Respirator – has only tiny pores 
which block droplet nuclei and 
relies on an air tight seal around 
the entire edge 
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Ventilation is the movement of air in a building and replacement 
of air in a building with air from outside.  Natural ventilation 
relies on open doors and windows to bring in air from the 
outside; ”controlled” implies that checks are in place to make 
sure that doors and windows are maintained in an open position 
that enhances ventilation.  Fans may also assist to distribute the 
air.  When fresh air enters a room it dilutes the concentration 
of particles in room air, such as droplet nuclei containing M. 
tuberculosis.  Designing waiting areas and examination rooms 
so that they maximize natural ventilation can help reduce the 
spread of TB.  In warm climates, this means open-air shelters 
with a roof to protect patients from sun and rain  (See Annex B.  
Information on Ventilation and Fans).
If patients are asked to provide sputum specimens for TB 
diagnosis onsite, they should always do so in an adequately 
ventilated booth or outside in the open air and away from other 
people, not in small rooms such as toilets or other enclosed 
areas.  (See Additional Resources  for more information on 
sputum collection booths.)
Studies show that M. tuberculosis is killed if the organisms 
are exposed to sufficient ultraviolet germicidal irradiation 
(UVGI). The major concerns about UVGI have been adverse 
reactions, such as acute and chronic skin and eye changes 
from overexposure if the UVGI is not installed and maintained 
properly.  Information on installation, cleaning, maintenance, 
and ongoing monitoring is available from Additional Resources.
PROTECTION OF HEALTH CARE WORKERS AND STAFF
INCREASING AWARENESS OF TB IN HEALTH CARE 
WORKERS AND STAFF
Investigations in countries in Africa, Asia, and South America 
have documented increased risk of TB disease or infection in 
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health care workers compared with the general population1.  
Those at risk include not just health care providers, but any 
staff, including volunteers, who have contact with persons with 
TB who have not yet been diagnosed and started on treatment.  
This could include porters and cleaners, as well as peer 
educators, adherence supporters, and volunteers working as 
counselors or in support groups.  PLWHA in these roles are at 
particular risk of rapid progression to TB disease if they become 
infected or re-infected due to exposure to M. tuberculosis in the 
facility.  They should be included in all training programs.  A third 
group, staff in correctional institutions and drug rehabilitation 
centers, also has been documented to have higher rates of TB 
infection and disease than the general population.  
The infection control measures recommended in this addendum 
should reduce the time persons with undiagnosed TB spend 
in HIV care settings and should improve ventilation and thus 
dilution of any M. tuberculosis particles in the environment.  
Nevertheless, the risk to staff will never be zero, and an 
additional aspect of protecting staff is promoting early 
recognition of TB disease and standard treatment.
Annual screening programs for TB disease, such as annual 
chest radiography, have not been shown to effectively reduce 
the amount of time between developing symptoms and 
diagnosis, as only a fraction of those who develop TB do so 
around the time of screening.  Instead, reminders that health 
care workers and other staff can develop TB, regardless of 
previous infection status or BCG vaccination, should occur with 
annual re-training on infection control.  It is recommended that 
staff be investigated for TB free of charge if they have a cough 
for two weeks or more.  The infection control plan should list 
designated staff members who should be contacted to initiate 
TB investigations, and reinforce that all services are confidential. 
Tuberculin skin testing can diagnose persons with TB infection 
who are most likely to develop TB disease, and who could 
potentially benefit from preventive treatment for TB infection.  
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However, TB preventive therapy programs are not yet widely 
implemented in resource-limited settings.9  In the new era 
of expanding access to care for persons living with HIV, TB 
preventive therapy for HIV-infected health care workers should 
be considered.
INCREASING ACCESS TO VOLUNTARY HIV COUNSELING 
AND TESTING
Encouraging and enabling health care workers and all staff 
to know their HIV status should be a priority of all health care 
services, and HIV care programs, in particular.  The rate of HIV 
infection among health care workers and staff may be similar 
to that of the broader community.  In the past, stigma, lack of 
confidentiality, and lack of treatment options have contributed 
to failure of health care workers to know their HIV status.  The 
expansion of the types of facilities addressed in this addendum 
is a sign that conditions are changing.  
Encouraging and enabling health care workers and all staff to 
know their HIV status can be facilitated by providing accessible, 
acceptable, confidential VCT, including periodic retesting, to 
staff.   Policies which prioritize ART for health care workers who 
need it can motivate them to know their HIV status.  Health 
care workers are a valuable resource, and they must receive 
adequate care and treatment to remain healthy and in the 
workforce. Furthermore, HIV-infected health care workers and 
other staff are at increased risk of developing TB disease if 
exposed in the workplace, and additional precautions should 
be taken to protect them.  Immunocompromised health care 
workers should be given opportunities to work in areas with a 
lower risk of exposure to TB.
Leadership and advocacy at the national level, from health 
care worker unions, and from medical and nursing associations 
will encourage health care workers to know their HIV status. 
Locally, programs can consider confidential testing options 
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such as use of rapid test kits at home; travel to another setting 
where one could be tested truly confidentially; bringing in a 
mobile counseling team (not from the community), who will not 
personally know any of the staff they test.  
There is no role for mandatory HIV testing of health care 
workers.
Health care workers have the same rights as all individuals to 
confidential HIV testing with counseling and conducted only with 
an informed consent.
Education directed to health care workers concerning HIV 
testing can also be linked to their role in educating patients and 
communities about the benefits of testing and knowing one’s 
HIV status and may further reduce stigma.   
MULTI-DRUG RESISTANT TB (MDRTB)
TB disease that is caused by organisms susceptible to the first-
line anti-TB drugs can generally be treated effectively without 
side effects from treatment, even in persons with HIV infection.  
TB disease caused by organisms resistant to at least the two 
most potent first-line drugs (isoniazid and rifampicin) is called 
multi-drug resistant TB (MDRTB).   Treating MDRTB takes 
longer and requires drugs that are more toxic, more expensive, 
often of limited availability in resource-limited settings, and 
generally less effective particularly in persons with HIV infection. 
Because of the risk of severe morbidity and mortality to 
HIV-infected persons from MDRTB, persons with known 
MDRTB should receive routine care outside of normal HIV 
care settings.  
HIV care facilities can obtain estimates of the prevalence of 
MDRTB in their community from the local TB program.  Through 
joint coordination and communication, the TB and HIV programs 
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can plan for how to care for these patients.  In areas where 
MDRTB is rare, special arrangements can be made to provide 
HIV care for an MDRTB patient.  In areas where MDRTB is 
more prevalent, specialized clinics can be established  (See 
Annex D.  FAQ on MDRTB).
DRUG REHABILITATION CENTERS AND CORRECTIONAL 
INSTITUTIONS
In many areas the proportion of persons with HIV infection in 
drug rehabilitation centers and correctional institutions (e.g., 
jails and prisons) is much higher than  in the general population.  
This is in part due to the high prevalence of HIV infection among 
injection drug users and sex workers, who in turn represent 
a large proportion of those incarcerated or in rehabilitation 
in some parts of the world.  Additionally, TB is spread even 
more readily in these settings than in outpatient settings 
because of the longer duration of potential exposure, crowded 
environment, poor ventilation, and limited access to health 
care services.  WHO has published guidelines for TB control in 
correctional institutions.10 These guidelines emphasize effective 
administrative and environmental controls, including screening 
detainees upon entry into the facility, and on a regular basis 
during times of prolonged detention.
Because the same TB infection control policies will protect HIV-
infected and uninfected detained persons as well as staff, it is 
not necessary to know who in the population at the institution is 
HIV-infected to conduct effective TB infection control.  However, 
voluntary, confidential HIV counseling and testing with consent 
can identify persons in need of HIV treatment with antiretroviral 
drugs, and prevention services such as preventive therapy for 
latent TB infection, which may contribute to TB control.  
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OPERATIONAL RESEARCH PRIORITIES
The recommendations in this addendum are based on current 
state of the art knowledge about TB infection control in 
resource-limited settings.  However, operational research can 
further inform practice.  Areas in which carefully collected and 
analyzed data would be useful include:
•	 Screening tools and algorithms to quickly identify 
potentially infectious TB patients presenting for HIV 
services;
•	 Mechanisms for referrals and links between HIV and TB 
services;
•	 Strategies for increasing the proportion of health care 
workers who know their HIV status and are able to 
access adequate care, including antiretroviral therapy 
and isoniazid preventive therapy;
•	 Designs for enhancing total air flow and air flow direction 
through controlled natural ventilation;
•	 Utility of ultraviolet germicidal irradiation in resource-
limited settings;
•	 Feasibility of prolonged treatment with isoniazid for 
prevention of TB in immunocompromised health care 
workers; and
•	 Interventions with health care workers that reduce stigma 
towards HIV and TB/HIV patients. 
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Glossary and Abbreviations
Bacille Calmette-Guérin (BCG) vaccine:  A live vaccine 
against TB derived from an attenuated strain of Mycobacterium 
bovis.
Droplet nuclei:  microscopic particles which are estimated 
at 1-5 microns in diameter and are produced when a person 
coughs, sneezes, shouts or sings.  Such particles may remain 
suspended in the air for hours.
Environmental control measures:  measures that can be used 
in high-risk areas to reduce the concentration of droplet nuclei 
in the air (e.g., maximizing natural ventilation or controlling the 
direction of airflow).
Exhaust ventilation:  an efficient environmental control 
technique (e.g. laboratory hoods, tents, booths, ventilation 
device) to contain airborne particles near the source before they 
can disperse widely into the air.
Face mask:  cloth or paper mask (e.g. surgical mask) that 
prevents the spread of micro-organisms from the wearer to 
others by capturing the large wet particles near the source 
(mouth); it does not provide sufficient protection from inhaling 
airborne infectious through.
Health care workers:  group of people that includes nurses, 
physicians, nursing and medical students, laboratory workers, 
counselors, and others who work in health care facilities and 
may be exposed to patients with communicable diseases.
HIV:  human immunodeficiency virus, the causative agent of 
AIDS.
Infection with M. tuberculosis:  the subclinical, latent infection 
with the organisms that cause TB, manifested by a positive 
tuberculin skin test, but without clinical evidence of disease.
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Infection control:  specific measures and work practices that 
reduce the likelihood of transmitting M. tuberculosis.
Isolation room:  single patient room with negative pressure 
ventilation where an infectious TB patient can be isolated from 
other patients.
Mechanical ventilation:  methods used to direct airflow to 
dilute and remove air, and to produce negative pressure in 
isolation rooms (e.g. window fan, exhaust ventilation systems).
Multidrug-resistant tuberculosis (MDRTB):  TB caused by 
strains of M. tuberculosis which are resistant to both isoniazid 
and rifampicin with or without resistance to other drugs.
Mycobacterium tuberculosis: the bacterium that causes TB.
Natural ventilation:  defined as natural air movement to 
achieve dilution and air exchange in an area with free-flow of 
ambient air (e.g. through the open windows).
PMTCT:  prevention of mother-to-child transmission of HIV 
infection
Respirators:  special type of closely-fitted mask with the 
capacity to filter particles 1 micron in size to protect from 
inhaling infectious droplet nuclei.
Smoke tubes:  devices used to monitor proper airflow direction 
and to determine the correct function of ventilation systems.
Tuberculin skin testing (TST):  intracutaneous injection of 
purified protein derivative (PPD) to identify persons who have 
been sensitized to mycobacterial antigens by infection with M. 
tuberculosis, environmental mycobacteria or administration of 
BCG.
                  

Tuberculosis (TB):  a clinically active, symptomatic disease 
caused by bacteria belonging to the M. tuberculosis complex (M. 
tuberculosis, M. bovis, M. africanum).
Ultraviolet germicidal irradiation (UVGI):  an environmental 
control measure to kill or inactivate micro-organisms like M. 
tuberculosis through exposure to UVGI.
VCT:  voluntary counseling and testing for HIV infection
Work practice and administrative controls:  defined as 
managerial or administrative measures which guide work 
practices to reduce significantly the risk of TB transmission 
by preventing the generation of droplet nuclei.  These include 
early diagnosis, prompt isolation or separation of infectious 
TB patients, prompt initiation of appropriate anti-tuberculosis 
treatment.
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ANNEX A.1.  SAMPLE INFECTION CONTROL PLAN
A. The plan will include, but not be limited to, the following 
policy areas:
1. Screening patients to identify persons with symptoms 
of TB disease or who report being under investigation 
or treatment for TB disease.
2. Providing face masks or tissues to persons with 
symptoms of TB disease (“TB suspects”) or who 
report being under investigation or treatment for TB 
disease (“TB suspects or cases”), and providing 
waste containers for disposal of tissues and masks.
3. Placing TB suspects and cases in a separate waiting 
area.
4. Triaging TB suspects and cases to the front of the line 
to expedite their receipt of services in the facility. 
5. Referring TB suspects to TB diagnostic services and 
confirming that TB cases are adhering with treatment.
6. Using and maintaining environmental control 
measures.
7. Educating staff periodically on signs and symptoms 
of TB disease, specific risks for TB for HIV-infected 
persons, and need for diagnostic investigation for 
those with signs or symptoms of TB.
8. Training and educating staff on TB, TB control, and 
the TB infection control plan.
9. Monitoring the TB infection control plan’s 
implementation. 
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B.  The facility will implement each policy by following the 
procedure(s) that accompany it.
Policy and Procedures 
Purpose:  Early identification, separation, receipt of services, 
and referral of patients with TB disease is essential in 
preventing spread of TB 
Lead:  _____________________ has the responsibility 
for overseeing the implementation of these policies and its 
procedures, and reports to (District health executive committee, 
etc).
Policy 1:  Screening patients to identify persons with symptoms 
or recent history of TB disease. 
Procedures:
1. Before patients enter an enclosed part of the facility, 
a designated staff person should ask each adult and 
any child capable of coughing forcefully (usually age 
14 or older) about symptoms or recent history of TB.  
The questioning should occur before patients wait in 
line for long periods to register or obtain services.
2. Many combinations of symptoms have been 
recommended as sensitive and specific for TB.  A 
simple screen is
“Do you have a cough?”  If patient answers” yes,” 
ask
“For how long have you been coughing?”
An adult who has coughed for two weeks or more may 
be considered a “TB suspect” for pulmonary TB.
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To determine whether a patient may be under 
investigation or a diagnosed case of TB, who may still 
be infectious, ask
“Are you being investigated or treated for TB?”
If the answer to either is “yes,” the screen classifies 
the patient as a TB suspect or case, and he should 
be managed as described in the procedures under 
policies 2 – 5 below.
3. As patients who are not identified as a TB suspect 
or case on the initial symptoms screen enter an 
examination room with the clinical officer, nurse, or 
counselor, they should again be asked the simple 
screening questions.  Those patients who report 
a cough of two or more weeks or who are being 
investigated or treated for TB should be managed 
as follows in the procedures under policies 2 – 5 
below.  Staff seeing patients in examination rooms 
should report patients they find to be a suspect or 
case to the infection control officer in a timely manner 
so that factors contributing to the potential exposure 
(e.g., an emergency or short staffing interfering with 
the designated person screening all patients) can be 
documented and corrected.
Policy 2:  Instructions on cough hygiene
     Procedures:
1. Patients who are found to be TB suspects or cases 
should immediately be informed about the importance 
of cough hygiene and be handed tissues (or pieces of 
cloth) and instructed to cover their mouths and noses 
when they cough.  Alternatively, patients should be 
given a face mask, and asked to wear it while in the 
facility. Patients should also be instructed to dispose 
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of used tissues or masks in identified no-touch 
receptacles and not on the ground.
When tissues, cloths or face masks are not available, 
clients should be instructed to lift their arm up and 
cover their nose and mouth with the inner surface of 
the arm or forearm when they cough or sneeze.  M. 
tuberculosis cannot be spread from the hands, but 
other serious lung infections can.
2. No-touch receptacles for disposal of used tissues and 
masks should be available in the waiting areas.
Policy 3:  Placing TB suspects and cases in a separate waiting 
area
     Procedures
1. A staff person should direct or escort the patient to 
a separate waiting area.  This special waiting area 
should have the highest natural ventilation possible.  
Patients should be assured of their place in the line 
for registration and/or services. 
Policy  4.  Triaging TB suspects and cases to the head of the 
line to receive services in the facility
 
     Procedures
1. TB suspects and cases should be moved to the head 
of the line for whatever services they want or need, 
e.g., VCT, medication refills, or medical investigation.  
This reduces the duration of potential exposure while 
they wait in the facility and may be an incentive to 
disclose information during screening.
Policy 5.  Referring TB suspects to TB diagnostic services 
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     Procedures
1. ____________________ is the designated staff 
person to counsel patients about obtaining TB 
diagnostic services.  
2. Patients will be referred to ____________________
________ (TB diagnostic center the HIV care facility 
has a previously negotiated agreement, see section 
__).
3. Patients should be given a card with the name, 
location, and operating hours of the TB diagnostic 
center.  The card should also have the name of the 
referring facility on it, with date of referral marked.  
These cards can be collected at the TB center and 
used as an anonymous check on number of referrals 
who successfully obtain TB services.  (See also the 
TB suspect and case form listed in Annex A2 below, 
which can be used to cross-reference referrals that 
are made/successful).
Policy 6.  Using and maintaining environmental control 
measures
     Procedures
1. ____________________ is the designated staff 
person to check on environmental control measures 
and maintain a log of monitoring and maintenance.  
2. Windows and doors should be checked on a daily 
basis to assure they are in proper position (open 
or closed as called for in the plan).  Generally, all 
windows and doors should be open when natural 
ventilation is the primary environmental control to 
allow for the free, unencumbered movement of air 
(e.g., across room, from window to door or vice 
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versa).  Generally, all windows and doors should be 
closed when using mechanical ventilation to ensure 
air movement in a controlled manner (air from supply 
vent and from slots either under or in door toward the 
exhaust vent).
3. Fans should be checked on a monthly basis to assure 
they are clean, are pulling (or pushing) the correct 
amount of air, and are pulling (or pushing) air in the 
correct direction.
Policy 7.  Providing confidential TB and HIV services to health 
care workers and staff
     Procedures
1. Health care workers and all other staff working 
at the facility should be educated about the signs 
and symptoms of TB and encouraged to seek 
investigations promptly if they develop symptoms and 
signs suggestive of TB.
2. Health care workers and other staff should be 
informed about the special specific risks for TB for 
HIV-infected persons (see section on Training of 
staff).
3.  Health care workers and staff should be encouraged 
to undergo HIV testing, and given information on 
relevant HIV care resources. 
4. Staff training should include reduction of stigma of TB 
and HIV.
5. _____________________ is responsible for 
determining when staff who develop TB disease may 
return to work.
6. Staff who develop TB disease may return to work 
                 

when determined to be no longer infectious after:
a. Having completed at least two weeks of standard 
anti-TB therapy; and
b. Exhibiting clinical improvement; and
c. Having continued medical supervision and 
monitoring of treatment until cured; and
d. Where possible, having had three consecutive 
negative sputum smears obtained on three 
different days with at least one morning specimen.  
(Note:  Frequent evaluation of sputum smear 
status may not be done routinely in resource-
limited settings.)
Policy 8.  Training of staff on all aspects of TB and the TB 
infection control plan
     Procedures
1. ____________________ is the designated staff 
person to provide training to new staff as it is hired 
and to maintain a log indicating who has had initial 
training.
2. ____________________ is the designated staff 
person to provide annual training to all staff and to 
maintain a log indicating who has attended training.  
This may be incorporated into a broader training topic 
or be stand alone TB infection control training.  
(See Annex A.3 for Sample Training Materials)
Policy 9.  Monitoring the TB infection control plan’s 
implementation
     
Procedures
1. Determine the frequency of the infection control plan
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a. During initiation of procedures, monitoring and 
evaluation should be done frequently, perhaps 
monthly or bi-monthly.
b. When procedures are running well, less 
frequent evaluation will be necessary – at a 
minimum, annually.
2. Evaluate the screening process
a. Were patients with significant cough missed 
when entering the facility and only detected at 
a later time or in the examination room?
b. What correctable factors were associated with 
these potential exposures?
3. Evaluate the success of referrals to the TB diagnostic 
center
a. Did referred patients access care?
b. Did referred patients have TB disease?
c. What changes in screening or referral process 
should be made, if any?
4. Evaluate the training process
a. Did all new staff receive training on TB infection 
control during their induction?
b. Did all staff receive annual re-training on TB 
infection control?
5. Revise the infection control plan to reflect changes in 
staff responsibilities, policies, and procedures
6. Develop a plan for correcting inappropriate practices 
or failure to adhere to institutional policies
a. identify incentives to participate fully and 
adhere to policies
b. identify corrective actions if policies are not 
followed
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Annex A.2.  Sample monitoring tools
_____________________ has the responsibility for overseeing 
the evaluation of the TB infection control policies and its 
procedures, and reports to (Program director, District health 
executive committee, etc).
___________________ has the responsibility for filling out The 
“TB case and suspect log” on a daily basis, entering the date, 
names of patients who were found to be a case or suspect 
that day, whether they were missed at intake screening, and to 
which facility they were referred.  
___________________ has the responsibility for conducting 
follow up on patients referred to a TB diagnostic facility and 
recording the outcomes of their investigation in the log.
 ___________________ has the responsibility to summarize 
and present the results of the screening process to relevant 
management and staff periodically.  
TB Case and Suspect Log
Date Patient 







(y/n)         
                








*Missed at intake = symptoms or history detected only after 
patient enters private room with clinician or counselor instead 
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of upon entry to the facility; or after numerous visits while 
symptomatic yet undetected: y=yes, n=no
**Outcomes:  TB diagnosed or confirmed=TB; TB ruled out 
after diagnostic investigation=not TB; Did not present to referral 
facility for investigation=NS (not seen).
Staff TB Infection Control Training Log
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Annex A.3.   Training materials for staff
The following is a set of overheads with a script that can be 
used by a training facilitator or lecturer.  Alternatively the staff 
person can read through the materials.  Users may modify as 
needed to meet local needs.
  
Annex A.3
Review of Tuberculosis 
Infection Control
Review of Tuberculosis 
Infection Control
                  

Why is there concern about TB 
infection control in HIV care 
facilities?
TB is the most common 
opportunistic infection and a 
leading cause of death in 
persons with HIV-infection
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Persons with undiagnosed, 
untreated, and potentially 
infectious (contagious) TB are 
often seen in HIV care settings
Health care workers and other 
staff at HIV care facilities are at 
particularly high risk of infection 
with TB because of frequent 
exposure to persons with 
infectious TB disease in the 
workplace
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Persons who work in HIV care 
settings need to know about TB, 
how it is transmitted, and how 
infection control procedures in 
the workplace can protect them
TB is caused by an organism 
called Mycobacterium 
tuberculosis
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TB is spread from person to 
person through the air
Transmission is the spread of an 
organism, such as M. 
tuberculosis, from one person to 
another
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Not everyone who is exposed to 
an infectious TB patient becomes 
infected
Infection begins when TB 
organisms in the droplet nuclei 
reach the small air sacs of the 
lung called alveoli
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TB infection means that tubercle 
bacilli are in the body but the 
immune system is keeping them 
under control
the lungs and the alveoli.
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People who have TB infection but 
not TB disease are NOT 
infectious
Infectiousness of People Known to Have 
or Suspected of Having TB Disease* 
Receiving adequate treatment 
for 2-3 weeks
Not receiving adequate 
treatment
No acid-fast bacilli on sputum 
smear
Acid-fast bacilli on sputum 
smear
Patient covering mouth when 
coughing
Patient not covering mouth 
when coughing
No cough or cough-inducing 
procedures
Cough or cough-inducing 
procedures
No cavity in the lungCavity in the lung
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TB disease develops when the 
immune system cannot keep the 
tubercle bacilli under control and 
the bacilli begin to multiply rapidly
TB disease can develop very 
soon after infection or many 
years after infection 
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Some conditions appear to 
increase the risk that TB infection 
will progress to disease
People who are infected with 
both M. tuberculosis and HIV are 
much more likely to develop TB 
disease than people who are 
infected only with M. tuberculosis
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Pulmonary TB occurs 
in the lungs 
Extrapulmonary TB occurs in 
places other than the lungs 
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Miliary TB occurs when tubercle 
bacilli enter the bloodstream and 
are carried to all parts of the 
body, where they grow and 
cause disease in multiple sites
Common symptoms of TB 
disease are persistent cough, 
bloody sputum, weight loss or 
loss of appetite, fever, or night 
sweats
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What factors affect the 
infectiousness 
of a TB patient? 
The infectiousness of a TB 
patient is directly related to the 
number of tubercle bacilli that he 
or she expels into the air
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Usually, only people with 
pulmonary or laryngeal TB are 
infectious
Patients who have a cavity in the 
lung may be expelling tubercle 
bacilli if they are coughing 
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Patients expel more tubercle 
bacilli if they have a cough that 
produces a lot of sputum
Patients who do not cover 
their mouths when they 
cough are more likely 
to expel tubercle bacilli 
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The presence of tubercle bacilli 
on a sputum smear indicates that 
the patient may be expelling 
tubercle bacilli
Patients who have not been 
receiving adequate treatment are 
much more likely to be infectious 
than patients who have been 
receiving adequate treatment
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Young children with TB disease 
are usually not infectious
Infectiousness appears to decline 
very rapidly after adequate 
treatment is started, but how 
quickly it declines varies from 
patient to patient
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TB Infection Control
About 30% of people who spend 
a lot of time with someone who 
has infectious TB disease 
become infected with M. 
tuberculosis
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TB is most likely to be 
transmitted when health care 
workers and patients come in 
contact with clients or patients 
who have unsuspected TB 
disease, who are not receiving 
adequate treatment, and who 
have not been isolated from 
others 
The main goal of an infection 
control program is to detect TB 
disease early and to promptly 
isolate and treat people who 
have TB disease and prevent 
others from getting TB
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There are two main ways to 
reduce the risk of TB 
transmission in the outpatient 
facility.  These are:
- work practice and administrative 
control measures and
- environmental control measures
Work practice and administrative 
controls mean establishing and 
following guidelines for 
•Promptly detecting patients who may 
have infectious TB disease
•Placing these patients in an area 
away from other patients
•Instructing them in cough hygiene
•Making sure they get a diagnostic 
evaluation, and then treatment if they 
have TB disease
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Patients who have signs or 
symptoms of TB disease should 
be placed in an area away from 
other patients, promptly seen for 
whatever purpose they came to 
the facility and then referred for a 
diagnostic evaluation
In hospitals and other inpatient settings, 
patients known to have TB disease or 
suspected of having TB disease ideally should 
be placed in a special TB isolation room right 
away
This is frequently not possible, so rapid 
collection and evaluation of sputum specimens 
with microscopy, and prompt initiation of 
treatment for those diagnosed with TB, are 
priorities
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In the outpatient facility, each 
client should be asked about 
symptoms and history of TB 
when he or she enters the facility.  
Adults and any children with the ability 
to cough forcefully should be asked:
“Do you have a cough?” If client 
answers yes, ask
“For how long have you been 
coughing?”
An adult who has coughed for 2 weeks 
or more is a “TB suspect” for   
pulmonary TB.
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To determine whether a client may be under 
evaluation or a diagnosed case of TB, who 
may still be infectious, ask
“Are you being evaluated or treated 
for TB?”
If the answer to either is yes, the client is 
classified as a TB suspect or case.
TB suspects and cases 
should be
•Given face masks or tissues
•Instructed in cough hygiene
•Directed to a separate waiting area
•Receive whatever services they are 
accessing quickly (ahead of the queue)
•Referred to a TB diagnostic and 
treatment facility
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Cough hygiene refers to the 
following measures:
• Covering the nose and mouth when 
coughing or sneezing
– Clients should be given tissues, face masks 
or scraps of cloth to assist in covering the 
mouth and nose
• The tissues, cloths or masks should be 
used to contain respiratory secretions; 
they should be disposed of in nearby no-
touch waste receptacles after use
When tissues, cloths or masks 
are not available, clients should 
be instructed to lift their arm up 
and cover their mouth and nose 
with the inner surface of the arm 
and forearm.  This is to keep 
germs away from the hands.  TB 
cannot be spread by the hands, 
but other respiratory germs such 
as influenza can.
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Environmental controls are the 
second line of defense for 
preventing the spread of TB in 
out-patient HIV care facilities. 
The main environmental control 
is natural and mechanical 
ventilation.  
Health care workers who may be 
exposed to TB should be 
included in a TB screening 
program
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Describe the infection control 
procedures at this facility
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Annex A.4 Education materials about TB for patients
Health care workers can use this guide to remind them of what 
to ask and say about TB during an initial information session 
with any patient.  Questions they can ask to find out how 
much the patient knows about TB are in bold on the left; and 
messages related to the questions are on the right.  They can 
emphasize different messages with different patients depending 
on the patient’s current knowledge about TB.
What is TB? TB is an illness (i.e., disease) caused 
by a germ that is breathed into the 
lungs.  TB germs can settle anywhere 
in the body, but we most often hear 
about TB of the lungs.  When the lungs 
are damaged by TB, a person coughs 
up sputum (mucus from the lungs) and 
cannot breathe easily.  Without correct 
treatment, a person can die from TB. 
What kind of 
symptoms do you 
think people with 
TB have?
People with TB of the lungs have a 
chronic cough, generally lasting for 
more than two weeks.  They can also 
cough up blood.  People with TB in 
any part of the body have fevers, night 
sweats, and weight loss.  People with 
these symptoms should tell a health 
care provider so they can be evaluated 
for TB.
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Have you ever 
known anyone 
with TB?  What 
happened to that 
person?
(just listen to their response)
Do you know 
that TB can be 
completely cured?
TB can be cured with the correct drug 
treatment.  The patient must take all of 
the recommended drugs for the entire 
treatment time (six or eight months) to 
be cured. Drugs for treatment of TB are 
provided free of charge, and treatment 
can be done without interrupting normal 
life and work.
How do you think 
that TB spreads?
TB spreads when an infected person 
coughs or sneezes, spraying TB germs 
into the air.  Others may breathe in 
these germs and become infected.
It is easy for germs to pass to family 
members when many people live 
closely together.  Anyone can get TB.  
However, not everyone who is infected 
with TB will become sick.
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How can someone 
with TB avoid 
spreading it?
There are several ways that a person 
with TB can prevent infecting others. 
An important step it to take regular 
treatment to become cured. Another 
measure to prevent infecting others is 
for infected persons to cover to their 
noses and moths when coughing or 
sneezing. Finally, infected persons 
should open windows and doors to 
allow fresh air into their homes.
Is TB a problem 
for people with HIV 
infection?
People living with HIV/AIDS are at 
extra risk of getting sick from TB 
because their body cannot fight off 
germs very well.  If someone develops 
symptoms of coughing for more than 
two weeks, coughing up blood, weight 
loss, fevers or night sweats, it is 
important to get checked for TB.  TB 
can be cured even in persons with HIV/
AIDS.
Source:  Stop TB Department, WHO:  Management of 
Tuberculosis Training for Health Facility Staff, Geneva, 2003 
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Annex B.  Information on Ventilation and Fans
Controlled natural ventilation
Natural ventilation refers to fresh dilution air that enters and 
leaves a room or other area though openings such as windows 
or doors.  Natural ventilation is controlled when openings are 
deliberately secured open to maintain air flow.  Unrestricted 
openings (that cannot be closed) on opposite sides of a room 
provide the most effective natural ventilation.
Propeller fans
Propeller fans may be an inexpensive way to increase the 
effectiveness of natural ventilation, by increasing the mixing of 
airborne TB as well as assisting in the direction of air movement 
by pushing or pulling of the air.
Types of propeller fans
Propeller fans include:
•	 Ceiling fans,
•	 Small fans that sit on a desk or other surface,
•	 Fans that stand on the floor, and
•	 Fans mounted in a window opening.
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Air mixing and removal
A propeller fan helps mix air in a room.  Mixing of air will reduce 
pockets of high concentrations, such as in the corners of a room 
or in the vicinity of patients where natural ventilation alone is not 
enough. The total number of infectious particles in the room will 
not change with mixing; however, the concentration of particles 
near the source will be reduced, and the concentration in other 
parts of the room may increase.
If this dilution effect is combined with a way to replace room air 
with fresh air, such as by opening windows and doors, the result 
will be fewer infectious particles in the room.
A room with an open window, open door, and a fan will have 
less risk than an enclosed room with no fan, an enclosed 
room with a fan, or a room with an open window but no fan.  
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In addition, mixing may increase the effectiveness of other 
environmental controls.  
Directional airflow 
If placed in or near a wall opening, propeller fans can also be 
used to enhance air movement into and out of a room.
Consider fans installed in the windows or through wall openings 
on the back wall of a building.  The fans exhaust air outside, 
away from people or areas where air may come back into 
the building.  If doors and windows in the front of the building 
are kept open, the overall effect should be to draw in fresh air 
through the front of the building and exhaust air through the 
rear.   Health care staff should be mindful of the direction of 
airflow to ensure the patient is closest to the exhaust fans and 
the staff are closest to the clean air source.  
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With this arrangement, the risk that TB will be spread is greater 
near the back of the building; however, once the contaminated 
air is exhausted, dilution into the environment will be fast.  
Exhaust fans
There are a wide variety of exhaust fan systems.  A system can 
be as simple as a propeller fan installed in the wall, or it could 
include a ceiling grille, a fan, and a duct leading to discharge on 
an outside wall or on the roof. 
Over time, dust and lint accumulate on exhaust fan blades.  The 
fans, motors, blades, and ducts become dirty and less air is 
exhausted.  For this reason, these systems should be cleaned 
regularly.
Checking natural ventilation
People can usually feel the existence or lack of air movement in 
a space.  A ventilated space has a slight draft.  In the absence 
of ventilation, air will feel stuffy and stale and odors will linger.  
Use the following checklist to assess natural ventilation in your 
waiting areas and examination rooms:
•	 Check air mixing and determine directional air movement 
in all parts of rooms or areas. One way to visualize air 
movement is to use incense sticks as described in these 
six steps.
1. Hold two incense sticks together and light them.
2. As soon as the incense starts to burn, blow out the 
flame.  Now the incense should produce a continuous 
stream of smoke.
3. Observe the direction of the smoke.
4. Observe how quickly the smoke dissipates.  This is a 
subjective test that may require some practice (see 
box below).  It does not give a definite result but is 
useful for comparing one room or area to another.
5. Check natural ventilation once a year after the 
prevailing wind patterns have been determined.  
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Recheck if any changes in the physical environment 
are made and confirm procedures for ensuring free 
movement of air are followed.
6. Keep records of all routine activities and dates.
Checking fans
•	 Check that all room fans are working and cleaned once a 
month.  Use cloth or vacuum cleaner to remove dust and 
lint from fans, grilles, and ducts.
•	 Check that exhaust fans are working and cleaned once 
a month.  Use cloth or vacuum cleaner to remove dust 
and lint from fans, grilles, and ducts.  Clean ducts behind 
grilles as far back as can be reached.  
•	 To check fans that have a grille, hold a tissue or piece of 
paper against the grille.  If the exhaust fan is working, the 
tissue or paper should be pulled against the grille.  
•	 Flow rates through exhaust fans and grilles can be 
measured using a simple velocity meter and a means to 
measure that velocity over a known cross-sectional area.  
The air flow rates can be calculated from simple velocity 
measurements (see Boxes 1 and 2).
•	 Air exchange rates (also called air-changes per hour) can 
be calculated as shown in boxes below.  If mechanically 
ventilating a room, the fan should provide a minimum of 
six air exchanges per hour.
•	 Keep records of all routine activities and dates.
 Box 1.  Estimating air velocity. 
 
Measure 0.5 meter distance and mark it on a tabletop.  Move your hand from one end to the other (0.5 
meters) in one second.  This is equivalent to 0.5 m/s!  In order to have directional control of 
contaminants in air, one should have air moving at least 0.5 m/s. 
 Example air flow calculation: 
 
Fan, duct, or box opening:   0 ..5 m high, 0.5 m wide 
Area =     0 .5 m x 0.5 m = 0.25 m2 
Average air velocity through fan, duct, or box opening:  2.5 m/s 
 
Average flow rate =  Area times average air velocity 
   0 .25 m2 x 2.5 m/s x 3600 s/hour =  2 250 m3/hour 
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 Box 2.  Example air exchange rate calculation 
 
Window opening:   0..5 m high, 0.5 m wide 
Window area = 0.5 m x 0.5 m = 0.25 m2 
Average air velocity through window:  0.5 m/s 
Room dimensions:   3  m wide, 5 m deep, and 3 m high 
Room volume = 3 m x 5 m x 3 m = 45 m3 
 
Average flow rate =  Area of window times average air velocity 
   0 .25 m2 x 0.5 m/s x 3600 s/hour = 450 m3/hour 
 
Air exchange rate = Average flow rate divided by room volume 
   450 m3/hour ÷ 45 m3 = 10 air exchanges per hour 
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Annex C.  Inpatient settings
Although the information in this addendum is directed primarily 
toward outpatient facilities, many of the recommendations also 
apply to inpatient facilities.  Specifically, measures regarding 
the infection control plan, health care worker and staff training, 
patient education, sputum collection, and triage and evaluation 
of suspect TB patients are similar.  Prevention of TB in hospitals 
requires a combined effort of infection control practices; more 
information on prevention of transmission of M. tuberculosis in 
hospital settings is available in Additional Resources.
One of the most effective means to reduce the risk of 
transmission of M. tuberculosis in hospital settings is to manage 
TB patients in the outpatient setting whenever possible.  Many 
patients can be managed entirely as outpatients, thereby 
avoiding hospitalization and the risk of exposing other patients 
and staff.  If hospitalized, patients should be re-evaluated 
frequently for possible discharge with continuation of therapy as 
outpatients. 
Ideally, infectious TB patients should be isolated from other 
patients so that others are not exposed to the infectious droplet 
nuclei that they generate.  If sputum smear is performed 
at the time of admission, those who have positive sputum 
smear results, and thus most infectious, should be isolated or 
separated from other patients.  
The hospital administration should attempt to:
•	 Limit the number of areas in the facility where exposure to 
potentially infectious TB patients may occur.
•	 Establish separate wards, areas or rooms for confirmed 
infectious TB patients.  These wards/areas should be located 
away from wards with non-TB patients, especially wards with 
pediatric or immunocompromised patients.
As in the outpatient setting, early identification, diagnosis, and 
treatment of TB cases is the highest priority.  Assigning the 
                 

role of “ward cough officer” to a staff member, who assures 
sputum specimen collection, rapid transport of specimens to the 
laboratory, and the delivery of results to the ward medical team, 
can be effective [8].  The ward cough officer may help to identify 
patients in need of investigation and to enforce TB infection 
control policies.
Radiology departments in hospitals often provide services to 
a variety of patient who may be at particularly high risk for TB, 
such as young children or immunocompromised patients.  
Radiology departments should attempt to:
•	 Schedule inpatient chest radiographs on infectious and 
suspect TB patients for non-busy times, such as the end of 
the afternoon.
•	 Provide coughing patients with a surgical mask to wear, or 
tissues or cloth to cover their mouths.
•	 Provide priority service to potentially infectious TB patients to 
minimize the length of time spent in the department.
•	 Restrict access to the radiology suite to patients and 
essential personnel only.
•	 Use the room with the best ventilation for taking images of 
potentially infectious TB patients.
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Annex D.  FAQ – Multi-drug-resistant TB (MDRTB)
What is MRDTB?
Multi-drug resistant TB, usually called MDRTB, is TB that is 
resistant to at least the two most important anti-TB drugs, 
isoniazid and rifampicin.  This means those two drugs do not 
effectively treat the TB disease.
Why is MDRTB a problem?
Because the two most important anti-TB drugs are not effective 
in treating MDR-TB, treatment requires drugs which are more 
toxic, more expensive, take longer to work and do not work as 
well (called “second line” drugs).  Also, these second line drugs 
are not widely available in resource-limited settings.
What causes MDRTB?
MDRTB may result from poor anti-TB treatment adherence or by 
incorrect treatment.  Adherence means taking the correct drugs 
with the correct doses at the correct time.  If the wrong drugs or 
the wrong combinations of drugs are prescribed, or providers fail 
to ensure that they are taken correctly on schedule, the bacteria 
causing TB may develop resistance to the drugs.  When this 
happens, the patient who initially had nonresistant TB develops 
drug-resistant TB.  If the patient who has MDRTB spreads TB to 
others, they will have MDRTB as well.  
How is MDRTB prevented?
MDRTB is a condition that can be prevented by following the 
international TB control strategy called DOTS, which stands 
for Directly Observed Treatment, Short-course.  Health care 
providers should always adhere to the National Tuberculosis 
Program Guidelines and use only the recommended anti-TB 
treatment regimens, drug combinations and drug dosages.  
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Anti-TB drugs, preferably Fixed Dose Combinations (one tablet 
contains all the drugs), of high quality should be available in 
regular and sufficient quantities.  Adherence to anti-TB 
treatment must be ensured with support, encouragement and 
monitoring of adherence by a relative, community volunteer, or a 
clinic nurse.
    
How do we know if a patient has MDRTB?
The diagnosis of MDRTB can only be made in a laboratory that 
can test sputum specimens for the presence of M. tuberculosis 
(the TB germ isolated by culture) and then test those TB isolates 
for drug resistance.  Patients who report interrupted treatment 
for TB, or failure to have symptoms improve after one to two 
months of TB treatment, may have drug-resistant TB, and 
should be separated from persons with HIV infection until their 
condition is evaluated.
Is there MDRTB is my community?
The District Medical Officer and national TB program can 
provide information on rates of MDRTB in specific communities.
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